微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 7.11% | 6.92% | -62.46% | 2/70 | 2.21% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 18.94% | 7.13% | 18.15% | 4/70 | 3.08% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 16.03% | 8.83% | 36.19% | 3/70 | 3% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 11.77% | 14.38% | 76.99% | 5/70 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 6.65% | 10.47% | -62.39% | 3/70 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 17.68% | 43.16% | 20.03% | 8/70 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 14.73% | 20.05% | 43.15% | 8/70 | 7.09% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 10.29% | 21.06% | 70.93% | 12/70 | 4.8% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 6.02% | 34.08% | -51.26% | 8/70 | 3.14% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 12.35% | 17.62% | 0.65% | 20/70 | 6.41% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 12.27% | 9.65% | 44.35% | 10/70 | 5.07% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 8.5% | 23.55% | 89.31% | 10/70 | 3.13% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 4.49% | 11.41% | -57.24% | 11/70 | 2.15% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 10.5% | -12.5% | -6.17% | 24/70 | 4.45% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 11.19% | 3.23% | 62.65% | 16/70 | 7.44% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 6.88% | -4.58% | 70.72% | 17/70 | 4.61% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 4.03% | 11.33% | -66.42% | 14/70 | 2.67% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 12% | -6.03% | 10.7% | 14/70 | 0.09% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 10.84% | -3.73% | 50.35% | 13/70 | 6.69% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 7.21% | 3.74% | 99.17% | 9/70 | 3.67% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 3.62% | -5.48% | -71.65% | 11/70 | 2.09% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 12.77% | -13.72% | 13.41% | 18/70 | 5.69% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 11.26% | -3.01% | 62.01% | 12/70 | 7.19% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 6.95% | -6.08% | 81.46% | 16/70 | 4.65% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 3.83% | -1.79% | -74.12% | 15/70 | 2.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 14.8% | -2.7% | 27.48% | 14/70 | 7.76% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 11.61% | -1.02% | 56.89% | 11/70 | 7.93% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 7.4% | -6.57% | 89.74% | 16/70 | 4.95% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 3.9% | -4.65% | -74.36% | 18/70 | 2.72% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 15.21% | 0.66% | 29.67% | 15/70 | 9.83% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 11.73% | 12.14% | 48.11% | 13/70 | 8.33% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 7.92% | 0.13% | 93.64% | 14/70 | 5.2% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 4.09% | -8.5% | -72.93% | 12/70 | 2.61% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 15.11% | -1.95% | 44.46% | 16/70 | 10% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 10.46% | 1.75% | 32.24% | 21/70 | 9.36% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 7.91% | 30.31% | 76.96% | 14/70 | 5.05% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 4.47% | 48.01% | -70.99% | 11/70 | 4.07% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 15.41% | 21.91% | 49.9% | 21/70 | 11.33% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 10.28% | 33.85% | 69.36% | 26/70 | 8.45% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 6.07% | 33.11% | 100.99% | 29/70 | 5.5% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 3.02% | 18.43% | -76.11% | 28/70 | 2.94% | 济川药业 | 21.37% | 行业排名> |